Cargando…

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients

BACKGROUND: Efficacy of vaccines and disease activity linked to immunization are major concerns among people with multiple sclerosis (pwMS). OBJECTIVE: To assess antibody responses to seasonal influenza antigens and vaccine-associated neuroaxonal damage utilizing serum neurofilament light chain (sNf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Tobias, Seiberl, Michael, Feige, Julia, Bieler, Lara, Radlberger, Richard F., O’Sullivan, Ciara, Pilz, Georg, Harrer, Andrea, Schwenker, Kerstin, Haschke-Becher, Elisabeth, Machegger, Lukas, Grimm, Jochen, Redlberger-Fritz, Monika, Buchmann, Arabella, Khalil, Michael, Kvas, Erich, Trinka, Eugen, Wipfler, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428149/ https://www.ncbi.nlm.nih.gov/pubmed/34512642 http://dx.doi.org/10.3389/fimmu.2021.718895

Ejemplares similares

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
por: Seiberl, Michael, et al.
Publicado: (2023)

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
por: Moser, Tobias, et al.
Publicado: (2022)

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
por: Moser, Tobias, et al.
Publicado: (2021)

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
por: Harrer, Christine, et al.
Publicado: (2021)

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study
por: Pilz, Georg, et al.
Publicado: (2019)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod
por: Harrer, Andrea, et al.
Publicado: (2015)

Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study
por: Moser, Tobias, et al.
Publicado: (2022)

Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS
por: Moser, Tobias, et al.
Publicado: (2020)

Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis
por: Harrer, Andrea, et al.
Publicado: (2012)

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
por: Harrer, Christine, et al.
Publicado: (2022)

Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis
por: Moser, Tobias, et al.
Publicado: (2021)

Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak
por: Mylonaki, Eirini, et al.
Publicado: (2022)

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
por: Feige, Julia, et al.
Publicado: (2022)

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study
por: Foettinger, Fabian, et al.
Publicado: (2023)

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities
por: Otto, Ferdinand, et al.
Publicado: (2021)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
por: O´Sullivan, C., et al.
Publicado: (2021)

The natural history of infantile neuroaxonal dystrophy
por: Altuame, Fadie D., et al.
Publicado: (2020)

11 Clinical Manifestations of Neuroaxonal Injury
por: Keleman, Audrey A., et al.
Publicado: (2023)

Unilateral delayed post-hypoxic leukoencephalopathy: a case report
por: Pfaff, Johannes A. R., et al.
Publicado: (2022)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Non-convulsive status epilepticus with right arm apraxia: A case report
por: Ladisich, Barbara, et al.
Publicado: (2020)

Infantile Neuroaxonal Dystrophy: Diagnosis and Possible Treatments
por: Babin, Patricia L., et al.
Publicado: (2018)

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
por: Mishra, Manoj Kumar, et al.
Publicado: (2014)

Atypical Childhood-onset Neuroaxonal Dystrophy in an Indian Girl
por: Jain, Sakshi, et al.
Publicado: (2019)

The infantile neuroaxonal dystrophy rating scale (INAD-RS)
por: Atwal, Paldeep S., et al.
Publicado: (2020)

Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis
por: You, Yuyi, et al.
Publicado: (2020)

Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis
por: Dujmovic, Irena
Publicado: (2011)

TECPR2 Associated Neuroaxonal Dystrophy in Spanish Water Dogs
por: Hahn, Kerstin, et al.
Publicado: (2015)

Pathological findings in a Dachshund-cross dog with neuroaxonal dystrophy
por: Pintus, Davide, et al.
Publicado: (2016)

Ultrastructural features of canine neuroaxonal dystrophy in a Papillon dog
por: TANAKA, Miyuu, et al.
Publicado: (2017)

Quantitative susceptibility mapping (QSM) evaluation of infantile neuroaxonal dystrophy
por: Fujiwara, Takuya, et al.
Publicado: (2019)

Signs of neuroaxonal injury in preeclampsia—A case control study
por: Andersson, Malin, et al.
Publicado: (2021)

Increased α‐tocopherol metabolism in horses with equine neuroaxonal dystrophy
por: Hales, Erin N., et al.
Publicado: (2021)

Infantile Neuroaxonal Dystrophy in Two Cases: Siblings with Different Presentations
por: ANSARI, Behnaz, et al.
Publicado: (2022)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex
por: Kapoor, Saketh, et al.
Publicado: (2016)

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study
por: Karamyan, Anush, et al.
Publicado: (2016)

Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy
por: Finno, Carrie J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gcica4nq14g4eblbudeqkmcrlg